Quantification of docetaxel and its main metabolites in human plasma by liquid chromatography/tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 19, Issue 17, 2005, Pages 2419-2426

  Guitton, J ^a,b   Cohen, S ^a   Tranchand, B ^c   Vignal, B ^a   Droz, J P ^d   Guillaumont, M ^a   Manchon, M ^a   Freyer, G ^a,d  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b INSERM   (France)

^c UNIVERSITÉ CLAUDE BERNARD LYON 1   (France)

^d CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; CHEMOTHERAPY; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; EXTRACTION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA (HUMAN);

ANALYTES; ANTINEOPLASTIC AGENTS; DOCETAXEL; HUMAN PLASMAS; HYDROXYLATED METABOLITES; LC-MS-MS; LIQUID CHROMATOGRAPHY COUPLED TO TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; LOWER LIMIT OF QUANTIFICATIONS;

METABOLITES;

EID: 24644497641     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/rcm.2072     Document Type: Article

References (20)

1. Ringel I, Horwitz SB. J. Natl. Cancer Inst. 1991; 83: 288.
2. Eisenhauer EA, Vermorken JB. Drugs 1998; 55: 5.
3. Sparreboom A, Van Tellingen O, Scherrenburg EJ, Boesen JJ, Huizing MT, Nooijen WJ, Versluis C, Beijnen JH. Drug Metab. Dispos. 1996; 24: 655.
4. Monegier B, Gaillard C, Sablé S, Vuilhorgne M. Tetrahedron Lett. 1994; 35: 3715.
5. Shou M, Martinet M, Korzekwa KR, Krausz KW, Gonzalez FJ, Gelboin HV. Pharmacogenetics 1998; 8: 391.
6. Royer I, Monsarrat B, Sonnier M, Wright M, Cresteil T. Cancer Res. 1996; 56: 58.
7. Engels FK, Ten Tije AJ, Baker SD, Lee CK, Loos WJ, Vulto AG, Verweij J, Sparreboom A. Clin. Pharmacol. Ther. 2004; 75: 448. DOI: 10.1016/j.clpt.2004.01. 001.
8. Guengerich FP. Annu. Rev. Pharmacol. Toxicol. 1989; 29: 241.
9. Rosing H, Lustig V, van Warmerdam LJ, Huizing MT, ten Bokkel Huinink WW, Schellens JH, Rodenhuis S, Bult A, Beijnen JH. Cancer Chemother. Pharmacol. 2000; 45: 213.
10. Rosing H, Lustig V, Koopman FP, ten Bokkel Huinink WW, Beijnen JH. J. Chromatogr. B Biomed. Sci. Appl. 1997; 696: 89.
11. Loos WJ, Verweij J, Nooter K, Stoter G, Sparreboom A. J. Chromatogr. B Biomed. Sci. Appl. 1997; 693: 437.
12. Garg MB, Ackland SP. J. Chromatogr. B Biomed. Sci. Appl. 2000; 748: 383.
13. Ciccolini J, Catalin J, Blachon MF, Durand A. J. Chromatogr. B Biomed. Sci. Appl. 2001; 759: 299.
14. Parise RA, Ramanathan RK, Zamboni WC, Egorin MJ. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2003; 783: 231.
15. Baker SD, Zhao M, He P, Carducci MA, Verweij J, Sparreboom A. Anal. Biochem. 2004; 324: 276. DOI: 10.1016/j.ab.2003.09.038.
16. Gustafson DL, Long ME, Zirrolli JA, Duncan MW, Holden SN, Pierson AS, Eckhardt SG. Cancer Chemother. Pharmacol. 2003; 52: 159. DOI: 10.1007/s00280-003-0622-z.
17. Hou W, Watters JW, McLeod HL. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2004; 804: 263. DOI: 10.1016/j.jchromb.2004.01.021.
18. Wang LZ, Goh BC, Grigg ME, Lee SC, Khoo YM, Lee HS. Rapid Commun. Mass Spectrom. 2003; 17: 1548. DOI: 10.1002/rcm.1091.
19. Mortier KA, Verstraete AG, Zhang GF, Lambert WE. J. Chromatogr. A 2004; 1041: 235. DOI: 10.1016/j.chroma.2004.04.026.
20. van Tellingen O, Beijnen JH, Verweij J, Scherrenburg EJ, Nooijen WJ, Sparreboom A. Clin. Cancer Res. 1999; 5: 2918.